Dark

Check out our Dark Pool Levels

AMTI
Applied Molecular Transport Inc. Common Stock
stock NASDAQ

Inactive

Dec 26, 2023

0.2630USD-14.304%(-0.0439)240,468

Pre-market

0.00USD-100.000%(-0.31)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Nov 15, 2021

08:00AM EST Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Bittoo Kanwar, M.D., chief medical officer, and Liz Bhatt, chief business and strategy officer, will participate in a fireside chat during the Virtual Jefferies London Healthcare Conference on Thursday, November 18, 2021 at 8:00 a.m. GMT. GlobeNewswire Inc

Nov 10, 2021

05:02PM EST Applied Molecular Q3 EPS $(0.68) Down From $(0.48) YoY Benzinga

04:01PM EST Top-line data readout for oral AMT-101 Phase 2 MARKET combination trial with anti-TNF in ulcerative colitis (UC) expected in H1 2022 GlobeNewswire Inc

Oct 15, 2021

07:44AM EDT The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO Benzinga

Oct 12, 2021

08:13AM EDT The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga

Oct 11, 2021

04:01PM EDT Management to highlight novel oral biologics technology platform, clinical programs and research activities GlobeNewswire Inc

Oct 7, 2021

08:24AM EDT The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results Benzinga

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Oct 1, 2021

07:56AM EDT The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO Benzinga

Sep 17, 2021

08:10AM EDT Applied Molecular Therapeutics To Present At 3 Upcoming Events In Sept., Oct.: Sept. 22, Oct. 15, Oct. 19 Benzinga

08:00AM EDT Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that the company will participate in the following investor events in September and October. GlobeNewswire Inc

07:36AM EDT The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold Benzinga

Sep 16, 2021

07:48AM EDT The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study Benzinga

Aug 24, 2021

04:01PM EDT Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the appointment of Holly Schachner, M.D. a seasoned and accomplished industry veteran to its Board of Directors. GlobeNewswire Inc

Aug 10, 2021

04:22PM EDT Applied Molecular Q2 EPS $(0.62) Up From $(1.11) YoY Benzinga

04:01PM EDT Top-line data readouts expected from four Phase 2 trials of oral AMT-101, consistent with previous guidance GlobeNewswire Inc

Jul 9, 2021

08:00AM EDT Once daily, oral AMT-101 was safe and well tolerated, and demonstrated trends of improvement in objective measures of inflammation: fecal calprotectin, CRP, and histology GlobeNewswire Inc

Jun 9, 2021

08:00AM EDT Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the JMP Securities Life Sciences Conference on Thursday, June 17, 2021 at 2:00 p.m. ET. GlobeNewswire Inc

May 13, 2021

04:38PM EDT Applied Molecular Q1 EPS $(0.58) Up From $(2.06) YoY Benzinga

04:01PM EDT Applied Molecular Transport Reports First Quarter 2021 Financial GlobeNewswire Inc

May 6, 2021

08:00AM EDT Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the BofA Securities 2021 Health Care Conference on Wednesday, May 12, 2021 at 2:00 p.m. ET. GlobeNewswire Inc

Apr 10, 2021

02:03PM EDT The Past Week's Notable Insider Buys Included Biotechs, Public Offerings, A SPAC And More Benzinga

Apr 6, 2021

04:01PM EDT Applied Molecular Transport Announces Closing of Public Offering GlobeNewswire Inc

Apr 1, 2021

02:37PM EDT Mid-Afternoon Market Update: Nasdaq Jumps Over 200 Points; AzurRx BioPharma Shares Slide Benzinga

12:04PM EDT Mid-Day Market Update: Crude Oil Rises Over 1%; BioXcel Therapeutics Shares Plummet Benzinga

07:46AM EDT The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract Benzinga

Mar 31, 2021

08:46PM EDT Applied Molecular Transport Announces Pricing of Public Offering GlobeNewswire Inc

Mar 30, 2021

08:06AM EDT The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings Benzinga

Mar 29, 2021

04:12PM EDT Applied Molecular Transport Reports 2.5M Share Offering Of Common Stock Benzinga

04:11PM EDT Applied Molecular Transport Announces Proposed Public Offering of GlobeNewswire Inc

Mar 22, 2021

08:00AM EDT Company continues to strengthen key functions of corporate leadership GlobeNewswire Inc

Mar 19, 2021

04:10PM EDT Applied Molecular Transport Announces Successfully Initiated Four Planned Phase 2 Trials For Oral AMT-101 With Enrollment Ongoing And Reported Q4 Earnings Benzinga

04:05PM EDT Successfully initiated four planned Phase 2 trials for oral AMT-101 with enrollment ongoing GlobeNewswire Inc

Mar 17, 2021

10:40AM EDT Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2021 Benzinga

08:26AM EDT JMP Securities Initiates Coverage On Applied Molecular with Outperform Rating, Announces Price Target of $92 Benzinga

Mar 9, 2021

08:00AM EST Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the Oppenheimer 31st Annual Healthcare Conference on Thursday, March 18, 2021 at 11:20 a.m. ET. GlobeNewswire Inc

Mar 1, 2021

08:02AM EST Applied Molecular Transport Announces First Subject Dosed in Phase 1a Trial of Oral AMT-126 Benzinga

08:00AM EST Company expands pipeline with second clinical program, AMT-126, an oral IL-22 fusion biologic therapy for diseases associated with intestinal epithelial barrier defects GlobeNewswire Inc

Feb 23, 2021

07:25AM EST The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts Benzinga

Feb 22, 2021

07:59AM EST 10 Biggest Price Target Changes For Monday Benzinga

06:20AM EST SVB Leerink Maintains Outperform on Applied Molecular, Raises Price Target to $74 Benzinga

Feb 19, 2021

07:25AM EST The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko Benzinga

Feb 18, 2021

08:14AM EST The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout Benzinga

Feb 17, 2021

08:00AM EST Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the SVB Leerink 10th Annual Global Healthcare Conference on Thursday, February 25, 2021 at 4:20 p.m. ET. GlobeNewswire Inc

07:27AM EST The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal Benzinga

Feb 11, 2021

11:21AM EST Stocks That Hit 52-Week Highs On Thursday Benzinga

Feb 9, 2021

08:10AM EST The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement Benzinga

Feb 4, 2021

07:22AM EST The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs Benzinga

Jan 26, 2021

08:07AM EST The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market Benzinga

Jan 19, 2021

08:03AM EST Applied Molecular Transport Appoints New CTO Benzinga

08:00AM EST Applied Molecular Transport Appoints Douglas Rich as Chief GlobeNewswire Inc

Dec 1, 2020

03:02AM EST The lockup period of Applied Molecular Transport Inc. (AMTI) ends tomorrow (Dec 2). RTTNews

Nov 24, 2020

08:00AM EST Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1, 2020 at 3:30 p.m. ET. GlobeNewswire Inc

Nov 12, 2020

04:23PM EST Applied Molecular Q3 EPS $(0.48) Up From $(1.07) YoY Benzinga

04:05PM EST - Company on track with comprehensive AMT-101 Phase 2 clinical program across multiple indications, including inflammatory bowel diseases and rheumatoid arthritis - GlobeNewswire Inc

Nov 11, 2020

08:00AM EST Applied Molecular Transport to Present at Jefferies Virtual London GlobeNewswire Inc

Nov 10, 2020

08:14AM EST Applied Molecular Transport Highlights Publication Of Preclinical Data Demonstrating Potential Of Novel Oral IL-10 Biologic Therapeutic For Inflammatory Diseases In The Journal Of Immunology Benzinga

08:00AM EST - AMT-101 (oral fusion protein of hIL-10 and AMT carrier) rapidly and efficiently transports through intestinal epithelia in healthy and inflamed conditions to target local intestinal tissue - GlobeNewswire Inc

Sep 22, 2020

08:00AM EDT Applied Molecular Transport to Present at Jefferies Next GlobeNewswire Inc

Aug 27, 2020

08:06AM EDT Applied Molecular Transport Announces First Patient Dosed In Phase 2 Study Of Oral AMT-101 In Ulcerative Colitis Benzinga

08:00AM EDT Applied Molecular Transport Announces First Patient Dosed in Phase GlobeNewswire Inc

Aug 11, 2020

04:04PM EDT Applied Molecular Transport Reports Q2 EPS $(1.11) Vs $(0.99) YoY Benzinga

04:00PM EDT - Company debuts with successful $177 million IPO - Plans to initiate three Phase 2 clinical trials for AMT-101 in 2020; anticipates top-line data readouts in 2H 2021 and 1H 2022 - On track to file IND/CTA by year-end 2020 for AMT-126, AMT?s second therapeutic product candidate GlobeNewswire Inc

Aug 5, 2020

08:00AM EDT Applied Molecular Transport Named as One of Three Finalists for GlobeNewswire Inc

Share